NTSR1 and neoplasm: This has been suggested as an alternative NTR prodrug because of its faster kinetics of reduction by NTR (Anlezark et al, 1995) and more efficient bystander effect in MCL cultures and human tumour xenografts (Wilson et al, 2002).